Despite Precautions, COVID-19 Pandemic Disproportionately Impacts People From Minoritized Backgrounds
A new study by researchers at Yale School of Medicine has found that people from racial and ethnic minoritized backgrounds have been disproportionately affected by the COVID-19 pandemic despite being more likely to engage in health and safety precautions than their white counterparts.
Public spaces as transformative creative wellness spaces: an evaluation of Musical Intervention
Musical Intervention (MI) is a public space that supports individuals who seek opportunities for creativity and connection with the broader community. A new study by Yale researchers sought to evaluate and understand MI through surveys, qualitative interviews, and ethnographic observations.Source: Social Work in Mental Health
Suicide Risk Jumps Soon After Dementia Diagnosis
Older patients recently diagnosed with dementia are at a significantly increased risk for suicide compared to their peers without dementia. Investigators found that individuals who were diagnosed with dementia had a 54% increased risk for suicide within the first year after diagnosis. The risk was particularly high among those aged 74 years and younger. Timothy Schmutte, PsyD, Assistant Professor of Psychiatry, was the study investigator.Source: Medscape
Desai to be honored with early career award from American Psychological Association
Miraj Desai, PhD, Instructor at the Yale Program for Recovery and Community Health at Yale School of Medicine, has been chosen to receive the Distinguished Early Career Contributions in Qualitative Inquiry Award from Division 5 of the American Psychological Association (Division of Quantitative and Qualitative Methods).
Colloquium will unify knowledge about mental health across disciplines
The first-ever Yale Mental Health Colloquium will bring together leading scholars in the fields of architecture, business, economics, education, law, neuroscience, psychiatry, public health, social work, and technology for a half-day conversation on the topic.
Department of Psychiatry announces clinical innovation awards
The Yale School of Medicine's Department of Psychiatry is pleased to announce the winners of its fifth annual Clinical Innovation in Psychiatry (CIIP) Awards. The winning programs will be presented at a special Grand Rounds presentation on Friday, November 21st.
Davidson receives Gralnick Prize for research into serious mental illness
Larry Davidson, PhD, professor of psychiatry and director of the Yale Program for Recovery and Community Health, was awarded the 2014 Alexander Gralnick Research Investigator Prize at the annual convention of the American Psychological Association. The prize recognizes "exceptional research and mentoring accomplishments in the area of serious mental illness."
Bellamy receives PCORI funds, patient advocacy award
Chyrell D. Bellamy, PhD, MSW, has been awarded funding by the Patient-Centered Outcomes Research Institute (PCORI) to evaluate the effectiveness of the recently-established Wellness Center at the Connecticut Mental Health Center (CMHC). Bellamy is an assistant professor of psychiatry and director of peer services and research at the Yale Program for Recovery and Community Health.
Helping mothers with mental illness hone their parenting skills
Daryn David, PhD, a Postdoctoral Fellow in Yale's Psychiatry Department, hopes to help mothers with mental illness get additional support, thanks to an American Psychological Foundation early career grant and a partnership with Connecticut's Department of Mental Health and Addiction Services.Source: Monitor on Psychology
Moderating the Relationship Between Ulcerative Colitis and Crohn’s Disease and Symptoms of PTSD
Alexandra Fuss, PhD, assistant professor of psychiatry, is first author of a paper in Journal of Clinical Gastroenterology that examines whether inflammatory bowel disease (IBD) patients endorse clinically significant symptoms of post-traumatic stress disorder (PTSD), and tests whether remission status and remission expectations effectively moderate the relationship between endorsements of PTSD symptoms and aspects of IBD.Source: Journal of Clinical Gastroenterology
Ketamine infusions improve symptoms of depression, anxiety and suicidal ideation, study says
People who got intravenous ketamine at three private ketamine infusion clinics had "significant improvement" in symptoms of depression, anxiety and suicidal ideation, according to a new study by Gerard Sanacora, PhD, MD George D. and Esther S. Gross Professor of Psychiatry, published in the Journal of Clinical Psychiatry.Source: CNN
De Aquino Awarded IMPOWR-YOU Grant to Study Pain Sensitivity, Opioid Use Disorder
Joao P. De Aquino, MD, assistant professor of psychiatry, has been awarded a pilot grant from the Integrative Management of Chronic Pain and Opioid Use Disorder for Whole Recovery-Yale and Organizations United (IMPOWR-YOU) Research Center to evaluate the relationship between pain sensitivity and brain synaptic density among people with opioid use disorder (OUD).
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study
COVID-19 patients with substance use disorders had greater likelihood of requiring critical interventions, such as ICU admission and ventilatory support. Substance use disorders and psychiatric diagnoses were also associated with a longer duration of hospitalization and greater number of hospital admissions.Source: The Journal of Clinical Psychiatry
Comparative effectiveness of group v. individual trauma-focused treatment for posttraumatic stress disorder in veterans
Group cognitive processing therapy (CPT) was associated with a slightly smaller reduction of PTSD symptom severity than individual CPT or prolonged exposure (PE) in veterans at the end of residential treatment. There were no differences at 4-month follow-up.Source: Psychological Medicine